R. Michael Carruthers - 22 Jun 2023 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role: Chief Financial Officer
Signature: /s/ John R. Moore Attorney-in-Fact for R. Michael Carruthers
Issuer symbol: EWTX
Transactions as of: 22 Jun 2023
Net transactions value: +$7,100
Form type: 4
Filing time: 26 Jun 2023, 16:28:45 UTC
Previous filing: 21 Jun 2023
Next filing: 18 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EWTX	Common Stock	Options Exercise	$7,100	+10,000	+53%	$0.7100^*	29,024	22 Jun 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EWTX	Stock Options (Right to buy)	Options Exercise	$0	-10,000	-4.8%	$0.000000	197,122	22 Jun 2023	Common Stock	10,000	$0.7100	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 2,898 shares purchased on May 15, 2023 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.
F2	1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date.